-
Sosei Heptares Acquires Idorsia’s Korea and Japan Units in JPY 65 Billion Deal
•
Japan-based Sosei Group Corporation (TYO: 4565) has announced that its subsidiary, Sosei Heptares, has acquired the South Korea and Japan-based units of Swiss firm Idorsia Ltd (SWX: IDIA) for a purchase price of approximately JPY 65 billion (USD 460 million), to be paid in cash. Expanding Sosei’s Portfolio in Asia-PacificThe…
-
Simcere Pharmaceuticals Licenses Idorsia’s Insomnia Therapy Daridorexant for Greater China
•
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced the establishment of a licensing agreement with Swiss firm Idorsia Ltd, securing exclusive development and commercialization rights to Idorsia’s insomnia therapy daridorexant in Greater China, including mainland China, Hong Kong, and Macau. The agreement also includes clinical research and development (R&D) activities.…
